全球骨生长刺激器市场 - 市场规模（按细分市场）、份额、监管、报销、治疗、预测（~2033）

骨生长刺激器市场主要由骨折固定和脊椎融合手术的数量所驱动。 这些手术的数量与老年人口的规模及其活动量有关。 据KOL称，与植入式设备相比，医生普遍更喜欢外部骨生长刺激器，因为它们更昂贵，需要额外的手术，并且增加感染的风险。 在外部刺激器中，超音波技术通常优于电刺激，因为电刺激的有效性尚未确定。

本报告研究和分析了全球骨生长刺激剂市场，并提供了有关每个细分市场的市场规模、市场趋势、竞争格局以及 COVID-19 影响的资讯。

市场模型的主要内容如下。

已上市的骨生长刺激剂和不断变化的竞争格局

• 对主要产业趋势的考虑
• 骨生长刺激器市场年收入与市场前景（按细分市场）（2015-2033 年）
• 按细分市场划分的手术总数、单位数量、平均售价和市场价值的详细数据

全球、区域和国家层面的特定市场考量

• 按地区细分全球趋势的特定市场定性资讯和国家/地区考虑因素
• 骨生长刺激剂市场的SWOT分析
• 骨生长刺激剂市场竞争动态的思考与趋势

透过对医疗保健系统的真实、全面的了解来促进市场了解。 市场进入部分还提供有关报销政策和监管环境的信息，使您能够更深入地研究市场动态。

• 各国医疗保健系统概览
• 按国家/地区划分的报销政策
• 各国医疗科技监理状况

目标公司

• Orthofix Medical Inc
• Bioventus Inc
• ZimVie Inc
• DJO Global Inc
• 其他

Abstract

Bone Growth Stimulators Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Orthopedic Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Bone Growth Stimulators Devices market for the year 2020 and beyond. Bone Growth Stimulators are used in procedures where bone regrowth and repair needs to be encouraged. As such, the Bone Growth Stimulators market is driven primarily by the number of procedures performed for fracture fixation and spinal fusion. These procedure volumes are married to the size of the elderly population as well as their activity level. According to KOLs, External Bone Growth Stimulators are widely preferred by physicians over Implantable devices, as Implantable Stimulators carry a higher price tag and require an additional surgery, increasing the risk of infection. Among External Stimulators, ultrasound technology is generally preferred over electrical stimulation as efficacy of electrical stimulation is not well established.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Bone Growth Stimulator Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Bone Growth Stimulator Devices market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Bone Growth Stimulator Devices market.
• Competitive dynamics insights and trends provided for Bone Growth Stimulator Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Orthofix Medical Inc, Bioventus Inc, ZimVie Inc, DJO Global Inc, and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Bone Growth Stimulators marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Bone Growth Stimulators market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Bone Growth Stimulators market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Bone Growth Stimulators market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Bone Growth Stimulators market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable